Serotonin reuptake inhibitors augmentation with cariprazine in patients with treatment-resistant obsessive-compulsive disorder: a retrospective observational study

被引:0
|
作者
Martiadis, Vassilis [1 ]
Pessina, Enrico [2 ]
Martini, Azzurra [2 ]
Raffone, Fabiola [1 ]
Cattaneo, Carlo I. [3 ]
De Berardis, Domenico [4 ]
Pampaloni, Ilenia [5 ]
机构
[1] ASL Napoli 1 Ctr, Dept Mental Hlth, Naples, Italy
[2] ASL CN2, Dept Mental Hlth, Bra, Italy
[3] ASL 12, Dept Mental Hlth, Biella, Italy
[4] ASL 4 Teramo, Dept Mental Hlth, Teramo, Italy
[5] South West London & St Georges Mental Hlth NHS Tru, Natl OCD BDD Serv, London, England
关键词
OCD; augmentation strategies; cariprazine; antipsychotic augmentation; refractory OCD; ANTIPSYCHOTIC AUGMENTATION; DOUBLE-BLIND;
D O I
10.1017/S1092852924000348
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Management of Treatment-Resistant Obsessive-Compulsive Disorder
    Gershkovich M.
    Wheaton M.G.
    Simpson H.B.
    Current Treatment Options in Psychiatry, 2017, 4 (4) : 357 - 370
  • [42] Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder
    Kayser, Reilly R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [43] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Koran, LM
    Birnbaum, M
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 206S - 207S
  • [44] TREATMENT OF SCHIZOPHRENIA WITH OBSESSIVE-COMPULSIVE FEATURES WITH SEROTONIN REUPTAKE INHIBITORS
    HWANG, MY
    MARTIN, AM
    LINDENMAYER, JP
    STEIN, D
    HOLLANDER, E
    AMERICAN JOURNAL OF PSYCHIATRY, 1993, 150 (07): : 1127 - 1127
  • [45] Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report
    Uzun, Oe
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (03) : 425 - 427
  • [46] Ondansetron augmentation for the management of obsessive-compulsive disorder in a patient with treatment-resistant schizophrenia
    Yadav, Suresh
    Takacs, Anna
    Pantelis, Christos
    Thomas, Naveen
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (08): : 830 - 831
  • [47] Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: A retrospective, open-label case series
    Van Ameringen, M
    Mancini, C
    Patterson, B
    Bennett, M
    DEPRESSION AND ANXIETY, 2006, 23 (01) : 1 - 5
  • [48] Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
    Maina, Giuseppe
    Pessina, Enrico
    Aguglia, Andrea
    Bogetto, Filippo
    CLINICAL MANAGEMENT ISSUES, 2009, 3 (01) : 15 - 26
  • [49] A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder
    Pigott, TA
    Seay, SM
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) : 101 - +
  • [50] Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials
    Dold, Markus
    Aigner, Martin
    Lanzenberger, Rupert
    Kasper, Siegfried
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (03): : 557 - 574